Walleye Capital LLC Purchases Shares of 52,915 CorVel Corp. $CRVL

Walleye Capital LLC acquired a new stake in CorVel Corp. (NASDAQ:CRVL) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 52,915 shares of the business services provider’s stock, valued at approximately $3,308,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Royal Bank of Canada boosted its position in shares of CorVel by 12.5% during the 1st quarter. Royal Bank of Canada now owns 51,261 shares of the business services provider’s stock valued at $5,739,000 after acquiring an additional 5,703 shares in the last quarter. AQR Capital Management LLC raised its position in CorVel by 4.0% in the first quarter. AQR Capital Management LLC now owns 26,468 shares of the business services provider’s stock worth $2,964,000 after purchasing an additional 1,013 shares in the last quarter. Integrated Wealth Concepts LLC lifted its stake in CorVel by 11.4% during the first quarter. Integrated Wealth Concepts LLC now owns 3,800 shares of the business services provider’s stock worth $425,000 after purchasing an additional 389 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in CorVel by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,846 shares of the business services provider’s stock worth $1,774,000 after purchasing an additional 702 shares during the period. Finally, Millennium Management LLC lifted its stake in CorVel by 127.4% during the first quarter. Millennium Management LLC now owns 48,182 shares of the business services provider’s stock worth $5,395,000 after purchasing an additional 26,990 shares during the period. 51.36% of the stock is owned by institutional investors.

Insider Transactions at CorVel

In other news, VP Jennifer Yoss sold 1,999 shares of the firm’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $61.02, for a total value of $121,978.98. Following the completion of the sale, the vice president directly owned 2,173 shares in the company, valued at approximately $132,596.46. This trade represents a 47.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Jeffrey J. Michael sold 9,000 shares of the firm’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $60.98, for a total value of $548,820.00. Following the completion of the sale, the director owned 559,721 shares of the company’s stock, valued at approximately $34,131,786.58. This trade represents a 1.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 13,249 shares of company stock worth $807,126. Insiders own 39.72% of the company’s stock.

Analysts Set New Price Targets

CRVL has been the topic of a number of recent research reports. Weiss Ratings raised CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 16th. Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, CorVel presently has an average rating of “Hold”.

CorVel Price Performance

NASDAQ CRVL opened at $65.73 on Friday. The stock’s 50 day simple moving average is $61.43 and its 200 day simple moving average is $57.64. CorVel Corp. has a one year low of $44.83 and a one year high of $93.71. The firm has a market cap of $3.35 billion, a PE ratio of 29.21 and a beta of 0.98.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 earnings per share (EPS) for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.The firm had revenue of $259.93 million during the quarter.

CorVel Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).